- Home
- XBIT vs ZTEK Comparison
XBIT vs ZTEK Comparison
Compare XBIT & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIT
- ZTEK
- Stock Information
- Founded
- XBIT 2005
- ZTEK 2008
- Country
- XBIT United States
- ZTEK Canada
- Employees
- XBIT N/A
- ZTEK N/A
- Industry
- XBIT Pharmaceuticals and Biotechnology
- ZTEK Major Chemicals
- Sector
- XBIT Health Care
- ZTEK Industrials
- Exchange
- XBIT Nasdaq
- ZTEK Nasdaq
- Market Cap
- XBIT 86.3M
- ZTEK 91.6M
- IPO Year
- XBIT 2015
- ZTEK N/A
- Fundamental
- Price
- XBIT $2.71
- ZTEK $0.91
- Analyst Decision
- XBIT
- ZTEK
- Analyst Count
- XBIT 0
- ZTEK 0
- Target Price
- XBIT N/A
- ZTEK N/A
- AVG Volume (30 Days)
- XBIT 52.7K
- ZTEK 834.0K
- Earning Date
- XBIT 11-12-2025
- ZTEK 11-13-2025
- Dividend Yield
- XBIT N/A
- ZTEK N/A
- EPS Growth
- XBIT N/A
- ZTEK N/A
- EPS
- XBIT N/A
- ZTEK N/A
- Revenue
- XBIT N/A
- ZTEK $678,078.00
- Revenue This Year
- XBIT N/A
- ZTEK N/A
- Revenue Next Year
- XBIT N/A
- ZTEK N/A
- P/E Ratio
- XBIT N/A
- ZTEK N/A
- Revenue Growth
- XBIT N/A
- ZTEK 2519.47
- 52 Week Low
- XBIT $2.50
- ZTEK $0.50
- 52 Week High
- XBIT $8.32
- ZTEK $1.84
- Technical
- Relative Strength Index (RSI)
- XBIT 34.88
- ZTEK 59.06
- Support Level
- XBIT $2.72
- ZTEK $0.65
- Resistance Level
- XBIT $3.61
- ZTEK $1.07
- Average True Range (ATR)
- XBIT 0.16
- ZTEK 0.12
- MACD
- XBIT -0.05
- ZTEK 0.03
- Stochastic Oscillator
- XBIT 2.25
- ZTEK 56.34
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.